ebomi
Colour theme
Sign in
Insider · CIK 0001422772

Kim Helen Susan

CIK 0001422772 Name as filed on the most recent filing

Filed as Kim Helen Susan (15)

58 transaction lines · from 15 filings · filed 2008-03-17 to 2026-01-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

58 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-01-12 Aktis Oncology, Inc.
AKTS 		P, Open-market purchase 812,455 acquired 18.00 14,624,190.00 Form 4, filing 0001193125-26-010566
2026-01-12 Aktis Oncology, Inc.
AKTS 		P, Open-market purchase 22,545 acquired 18.00 405,810.00 Form 4, filing 0001193125-26-010566
2021-08-27 Applied Molecular Transport Inc.
AMTI 		S, Open-market sale 701 disposed 30.76 21,564.37 Form 4, filing 0001209191-21-053763
2021-08-27 Applied Molecular Transport Inc.
AMTI 		S, Open-market sale 250 disposed 31.44 7,860.50 Form 4, filing 0001209191-21-053763
2021-08-26 Applied Molecular Transport Inc.
AMTI 		S, Open-market sale 13,505 disposed 30.12 406,770.60 Form 4, filing 0001209191-21-053763
2021-08-26 Applied Molecular Transport Inc.
AMTI 		S, Open-market sale 558 disposed 31.01 17,303.58 Form 4, filing 0001209191-21-053763
2021-08-25 Applied Molecular Transport Inc.
AMTI 		S, Open-market sale 9,478 disposed 30.08 285,075.49 Form 4, filing 0001209191-21-053411
2021-08-24 Applied Molecular Transport Inc.
AMTI 		S, Open-market sale 505 disposed 30.03 15,165.15 Form 4, filing 0001209191-21-053411
2021-08-24 Applied Molecular Transport Inc.
AMTI 		S, Open-market sale 3 disposed 30.04 90.12 Form 4, filing 0001209191-21-053411
2021-07-02 Applied Molecular Transport Inc.
AMTI 		S, Open-market sale 198,759 disposed 43.30 8,606,264.70 Form 4, filing 0001209191-21-045674
2021-07-02 Applied Molecular Transport Inc.
AMTI 		S, Open-market sale 1,241 disposed 46.31 57,465.87 Form 4, filing 0001209191-21-045674
2017-09-25 Kite Pharma, Inc.
KITE 		S, Open-market sale 3,171 disposed 179.66 569,714.23 Form 4, filing 0001209191-17-054199
2017-08-10 Kite Pharma, Inc.
KITE 		S, Open-market sale 6,251 disposed 120.09 750,682.59 Form 4, filing 0001209191-17-048786
2017-08-08 Kite Pharma, Inc.
KITE 		S, Open-market sale 31,165 disposed 120.40 3,752,266.00 Form 4, filing 0001209191-17-048434
2017-08-08 Kite Pharma, Inc.
KITE 		S, Open-market sale 18,936 disposed 119.94 2,271,183.84 Form 4, filing 0001209191-17-048434
2017-08-08 Kite Pharma, Inc.
KITE 		S, Open-market sale 13,274 disposed 121.37 1,611,065.38 Form 4, filing 0001209191-17-048434
2017-08-08 Kite Pharma, Inc.
KITE 		S, Open-market sale 11,074 disposed 115.02 1,273,731.48 Form 4, filing 0001209191-17-048434
2017-08-08 Kite Pharma, Inc.
KITE 		S, Open-market sale 3,800 disposed 118.61 450,718.00 Form 4, filing 0001209191-17-048434
2017-08-08 Kite Pharma, Inc.
KITE 		S, Open-market sale 1,700 disposed 117.27 199,359.00 Form 4, filing 0001209191-17-048434
2017-07-31 Kite Pharma, Inc.
KITE 		S, Open-market sale 15,804 disposed 108.75 1,718,685.00 Form 4, filing 0001209191-17-046974
2017-07-31 Kite Pharma, Inc.
KITE 		S, Open-market sale 7,448 disposed 109.74 817,343.52 Form 4, filing 0001209191-17-046974
2017-07-31 Kite Pharma, Inc.
KITE 		S, Open-market sale 2,725 disposed 110.55 301,248.75 Form 4, filing 0001209191-17-046974
2017-07-31 Kite Pharma, Inc.
KITE 		S, Open-market sale 672 disposed 111.60 74,995.20 Form 4, filing 0001209191-17-046974
2017-06-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 2,400 disposed 72.45 173,880.00 Form 4, filing 0001209191-17-037803
2017-05-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 2,400 disposed 82.12 197,088.00 Form 4, filing 0001209191-17-029754
2017-04-03 Kite Pharma, Inc.
KITE 		S, Open-market sale 2,400 disposed 81.80 196,320.00 Form 4, filing 0001209191-17-024743
2017-03-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 600 disposed 79.26 47,556.00 Form 4, filing 0000899243-17-005888
2017-03-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 400 disposed 79.92 31,968.00 Form 4, filing 0000899243-17-005888
2017-03-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 300 disposed 70.29 21,087.00 Form 4, filing 0000899243-17-005888
2017-03-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 200 disposed 76.93 15,386.00 Form 4, filing 0000899243-17-005888
2017-03-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 200 disposed 75.52 15,104.00 Form 4, filing 0000899243-17-005888
2017-03-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 200 disposed 72.69 14,538.00 Form 4, filing 0000899243-17-005888
2017-03-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 200 disposed 71.23 14,246.00 Form 4, filing 0000899243-17-005888
2017-03-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 200 disposed 68.95 13,790.00 Form 4, filing 0000899243-17-005888
2017-03-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 100 disposed 73.64 7,364.00 Form 4, filing 0000899243-17-005888
2017-02-28 Kite Pharma, Inc.
KITE 		S, Open-market sale 18,072 disposed 65.81 1,189,318.32 Form 4, filing 0000899243-17-005888
2017-02-28 Kite Pharma, Inc.
KITE 		S, Open-market sale 10,326 disposed 66.32 684,820.32 Form 4, filing 0000899243-17-005888
2017-02-28 Kite Pharma, Inc.
KITE 		S, Open-market sale 9,049 disposed 71.16 643,926.84 Form 4, filing 0000899243-17-005888
2017-02-28 Kite Pharma, Inc.
KITE 		S, Open-market sale 2,553 disposed 69.63 177,765.39 Form 4, filing 0000899243-17-005888
2017-02-28 Kite Pharma, Inc.
KITE 		S, Open-market sale 2,500 disposed 67.49 168,725.00 Form 4, filing 0000899243-17-005888
2017-02-28 Kite Pharma, Inc.
KITE 		S, Open-market sale 2,400 disposed 63.00 151,200.00 Form 4, filing 0000899243-17-005888
2017-02-28 Kite Pharma, Inc.
KITE 		S, Open-market sale 1,800 disposed 71.65 128,970.00 Form 4, filing 0000899243-17-005888
2017-02-28 Kite Pharma, Inc.
KITE 		S, Open-market sale 900 disposed 68.74 61,866.00 Form 4, filing 0000899243-17-005888
2017-02-28 Kite Pharma, Inc.
KITE 		S, Open-market sale 300 disposed 72.60 21,780.00 Form 4, filing 0000899243-17-005888
2016-12-20 Kite Pharma, Inc.
KITE 		S, Open-market sale 936 disposed 50.86 47,604.96 Form 4, filing 0001209191-16-156549
2016-08-15 Kite Pharma, Inc.
KITE 		S, Open-market sale 2,400 disposed 63.01 151,228.80 Form 4, filing 0001209191-16-137390
2016-08-12 Kite Pharma, Inc.
KITE 		S, Open-market sale 33,500 disposed 60.08 2,012,596.25 Form 4, filing 0001209191-16-137390
2008-03-14 Kosan Biosciences Inc
KOSN 		P, Open-market purchase 4,900 acquired 1.65 8,085.00 Form 4, filing 0001181431-08-019123
2008-03-14 Kosan Biosciences Inc
KOSN 		P, Open-market purchase 2,641 acquired 1.70 4,489.70 Form 4, filing 0001181431-08-019123
2008-03-14 Kosan Biosciences Inc
KOSN 		P, Open-market purchase 2,400 acquired 1.66 3,984.00 Form 4, filing 0001181431-08-019123

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 13
  • Open-market sale 45
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Kim Helen Susan, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001422772

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.